HAIFA, Israel, July 16, 2024 /PRNewswire/ — Nurami Medical, a pioneering developer of soft tissue repair solutions, announced today that it has been awarded blended financing which includes a €2.5 million grant and additional equity investment from the European Innovation Council (EIC) Horizon Accelerator program. This substantial award recognizes Nurami’s innovative technology and its potential to transform the soft tissue repair industry.
Nurami Medical Awarded a €2.5 Million EIC Grant to Accelerate Soft Tissue Repair
